A washingtonpost.com article from: goldyer1@...

[Guest guest]

You have been sent this message from goldyer1@... as a courtesy of

washingtonpost.com

Personal Message:

To begin to flesh out the drug industry's misbehavior.

Petitions to FDA Sometimes Delay Generic Drugs

By Marc Kaufman

A procedure designed to alert the Food and Drug Administration to scientific

and safety issues is getting a hard look from members of Congress, who say they

are concerned that it may be getting subverted by the brand-name drug industry.

To view the entire article, go to

http://www.washingtonpost.com/wp-dyn/content/article/2006/07/02/AR2006070200840.\

html?referrer=emailarticle

Would you like to send this article to a friend? Go to

http://www.washingtonpost.com/ac2/wp-dyn/emailafriend?contentId=AR2006070200840 & \

sent=no & referrer=emailarticle

Want the latest news in your inbox? Check out washingtonpost.com's e-mail

newsletters:

http://www.washingtonpost.com/ac2/wp-dyn?node=admin/email & referrer=emailarticle

Washingtonpost.Newsweek Interactive

c/o E-mail Customer Care

1515 N. Courthouse Road

Arlington, VA 22201

© 2002 - 2006 The Washington Post Company